🇺🇸 FDA
Patent

US 10143709

Use of ASC and ASC-CM to treat ARDS, SARS, and MERS

granted A61KA61K35/28

Quick answer

US patent 10143709 (Use of ASC and ASC-CM to treat ARDS, SARS, and MERS) held by The United States of America Department of Veteran Affairs As Represented By The Technology Transfer Program expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America Department of Veteran Affairs As Represented By The Technology Transfer Program
Grant date
Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K35/28